Brief: Carerx Reports Continued Strong Growth For Q3 Of 2022
Nov 9 (Reuters) - Carerx Corp CRRX.TO :
* CARERX REPORTS CONTINUED STRONG GROWTH FOR THE THIRD
QUARTER OF
2022
* Q3 REVENUE C$97.4 MILLION
* QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.04
Source text for Eikon: ID:nCNW0Y1H4a
Further company coverage: CRRX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CareRx
See all newsCanada's CareRx Q2 revenue rises, slightly misses estimates
Canada's CareRx Q1 revenue and adjusted EBITDA rise
Canada's CareRx quarterly revenue slightly beats estimates on beds serviced growth
Long-term care pharmacy CareRx Q3 revenue misses analyst expectations
Canada's CareRx Q2 revenue in-line with estimates